Published by Josh White on 23rd February 2022
(Sharecast News) - Biotechnology company BiVictriX Therapeutics announced the expansion of its therapeutic pipeline on Wednesday, with two additional programmes - 'BVX002' and 'BVX003' - both entering the early stages of drug development.
URL: http://www.digitallook.com/dl/news/story/32484222/...